» Articles » PMID: 15574198

Blood Coagulation and the Risk of Atherothrombosis: a Complex Relationship

Overview
Journal Thromb J
Publisher Biomed Central
Date 2004 Dec 3
PMID 15574198
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The principles of Virchov's triad appear to be operational in atherothrombosis or arterial thrombosis: local flow changes and particularly vacular wall damage are the main pathophysiological elements. Furthermore, alterations in arterial blood composition are also involved although the specific role and importance of blood coagulation is an ongoing matter of debate. In this review we provide support for the hypothesis that activated blood coagulation is an essential determinant of the risk of atherothrombotic complications. We distinguish two phases in atherosclerosis: In the first phase, atherosclerosis develops under influence of "classical" risk factors, i.e. both genetic and acquired forces. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor - factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. The dominant effect of coagulation in this phase is anticoagulant, i.e. thrombin enhances protein C activation through its binding to endothelial thrombomodulin.The second phase is characterized by advancing atherosclerosis, with greater impact of inflammation as indicated by an elevated level of plasma C-reactive protein, the result of increased production influenced by interleukin-6. Inflammation overwhelms protective anticoagulant forces, which in itself may have become less efficient due to down regulation of thrombomodulin and endothelial cell protein C receptor (EPCR) expression. In this phase, the inflammatory drive leads to recurrent induction of tissue factor and assembly of catalytic complexes on aggregated cells and on microparticles, maintaining a certain level of thrombin production and fibrin formation. In advanced atherosclerosis systemic and vascular wall driven coagulation becomes more important and elevated levels of D-dimer fragments should be interpreted as markers of this hypercoagulability.

Citing Articles

Higher post procedural bleeding in patients with advanced chronic kidney disease undergoing percutaneous coronary intervention.

Movahed M, Aghdasi S, Hashemzadeh M Am J Blood Res. 2024; 14(1):1-5.

PMID: 39034970 PMC: 11258550. DOI: 10.62347/IQUS3924.


Effect of Breastfeeding Duration on Coagulation in Women With and Without History of Gestational Diabetes Mellitus.

Fritsche L, Loffler D, Kantartzis K, Flehmig G, Roden M, Fritsche A J Clin Endocrinol Metab. 2024; 109(10):2571-2578.

PMID: 38487818 PMC: 11403320. DOI: 10.1210/clinem/dgae172.


The Effect of a Dietary Supplement Containing Rhamnan Sulfate from on Carotid Atherosclerotic Plaque: A Case Series.

Burke K, Jennings I Integr Med (Encinitas). 2024; 22(6):30-37.

PMID: 38404609 PMC: 10886398.


Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway.

Lu Y, Li D, Huang Y, Sun Y, Zhou H, Ye F J Inflamm Res. 2023; 16:1027-1042.

PMID: 36926276 PMC: 10013575. DOI: 10.2147/JIR.S393850.


Plasma levels of thrombin and activated protein C in patients with acute myocardial Infarction: An observational study.

Becher T, Schimanski R, Muller J, Baumann S, Klenantz S, Potzsch B Int J Cardiol Heart Vasc. 2022; 42:101097.

PMID: 35928794 PMC: 9343411. DOI: 10.1016/j.ijcha.2022.101097.


References
1.
Ananyeva N, Kouiavskaia D, Shima M, Saenko E . Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood. 2002; 99(12):4475-85. DOI: 10.1182/blood-2001-11-0140. View

2.
Selwyn A . Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol. 2003; 91(12A):3H-11H. DOI: 10.1016/s0002-9149(03)00428-4. View

3.
Slofstra S, Spek C, Ten Cate H . Disseminated intravascular coagulation. Hematol J. 2003; 4(5):295-302. DOI: 10.1038/sj.thj.6200263. View

4.
Plow E, Hoover-Plow J . The functions of plasminogen in cardiovascular disease. Trends Cardiovasc Med. 2004; 14(5):180-6. DOI: 10.1016/j.tcm.2004.04.001. View

5.
Aird W . Hemostasis and irreducible complexity. J Thromb Haemost. 2003; 1(2):227-30. DOI: 10.1046/j.1538-7836.2003.00062.x. View